Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioEnergy Life Science (BELS) is a biotechnology company specializing in the development of functional ingredients for metabolic health and cellular energy restoration. The company is globally recognized for its flagship product, Bioenergy Ribose, a patented D-ribose ingredient that facilitates the synthesis of adenosine triphosphate (ATP) to enhance energy levels in cardiac and skeletal muscle. BELS targets a variety of indications where energy depletion is a primary factor, including fibromyalgia, chronic fatigue syndrome, and cardiovascular conditions. Recently, the company has expanded its portfolio to include RiaGev, a proprietary blend of Ribose and Nicotinamide designed to boost NAD+ levels and support healthy aging and mitochondrial function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioEnergy International.